189 related articles for article (PubMed ID: 33628041)
21. Pembrolizumab-induced type 1 diabetes.
Maia A; Soares DM; Azevedo S; Pereira T; Amaral C
J Oncol Pharm Pract; 2024 May; ():10781552241255699. PubMed ID: 38766907
[TBL] [Abstract][Full Text] [Related]
22. A Journey of Diagnosing a Case of Immune Checkpoint Inhibitor Pembrolizumab-Induced Diabetes Mellitus.
Tang M; Nakapakorn C; Meng S
JCEM Case Rep; 2024 Jan; 2(1):luad126. PubMed ID: 38116162
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma.
Aleksova J; Lau PK; Soldatos G; McArthur G
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27881588
[TBL] [Abstract][Full Text] [Related]
24. Diabetic Ketoacidosis With the Use of Alpelisib in a Patient With Metastatic Breast Cancer Without Diabetes.
Polisetty L; Teresa Selvin S; Tan JW
JCEM Case Rep; 2024 Apr; 2(4):luae023. PubMed ID: 38524964
[TBL] [Abstract][Full Text] [Related]
25. Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes Mellitus.
Clotman K; Janssens K; Specenier P; Weets I; De Block CEM
J Clin Endocrinol Metab; 2018 Sep; 103(9):3144-3154. PubMed ID: 29955867
[TBL] [Abstract][Full Text] [Related]
26. Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma.
Changizzadeh PN; Mukkamalla SKR; Armenio VA
J Immunother Cancer; 2017 Dec; 5(1):97. PubMed ID: 29254501
[TBL] [Abstract][Full Text] [Related]
27. Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis.
Thawabi M; Studyvin S
N Am J Med Sci; 2015 Jun; 7(6):291-4. PubMed ID: 26199928
[TBL] [Abstract][Full Text] [Related]
28. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
29. Diabetic ketoacidosis induced by a single dose of pembrolizumab.
Maamari J; Yeung SJ; Chaftari PS
Am J Emerg Med; 2019 Feb; 37(2):376.e1-376.e2. PubMed ID: 30361152
[TBL] [Abstract][Full Text] [Related]
30. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
Andrews TJ; Cox RD; Parker C; Kolb J
J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
[TBL] [Abstract][Full Text] [Related]
31. Diabetic Ketoacidosis: An Adverse Reaction to Immunotherapy.
Keerty D; Das M; Hallanger-Johnson J; Haynes E
Cureus; 2020 Sep; 12(9):e10632. PubMed ID: 33123445
[TBL] [Abstract][Full Text] [Related]
32. Severe hypertriglyceridemia: A rare complication of diabetic ketoacidosis in a 3-year-old with SARS-CoV-2 infection.
Basta C; Ramones K; Agarwal S; Marino G; Ghanny S
J Clin Transl Endocrinol Case Rep; 2021 Dec; 22():100099. PubMed ID: 34751241
[TBL] [Abstract][Full Text] [Related]
33. Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report.
Iwata Y; Matsuhashi N; Takahashi T; Suetsugu T; Fukada M; Yasufuku I; Imai T; Tanahashi T; Matsui S; Imai H; Tanaka Y; Yamaguchi K; Yoshida K
Mol Clin Oncol; 2019 Aug; 11(2):189-191. PubMed ID: 31281655
[TBL] [Abstract][Full Text] [Related]
34. Euglycemic Diabetic Ketoacidosis in Pregnancy: A Case Report and Review of Current Literature.
Jaber JF; Standley M; Reddy R
Case Rep Crit Care; 2019; 2019():8769714. PubMed ID: 31531246
[TBL] [Abstract][Full Text] [Related]
35. Canagliflozin-associated diabetic ketoacidosis: a case report.
Chai PR; Bonney C; Blohm E; Boyer EW; Babu KM
Toxicol Commun; 2017; 1(1):2-5. PubMed ID: 29978156
[TBL] [Abstract][Full Text] [Related]
36. Metformin in an HIV-infected patient with protease inhibitor-induced diabetic ketoacidosis.
Hughes CA; Taylor GD
Ann Pharmacother; 2001; 35(7-8):877-80. PubMed ID: 11485138
[TBL] [Abstract][Full Text] [Related]
37. Pembrolizumab-Induced Diabetic Ketoacidosis: A Review of Critical Care Case.
Sankar K; Macfarlane M; Cooper O; Falk J
Cureus; 2021 Oct; 13(10):e18983. PubMed ID: 34820238
[TBL] [Abstract][Full Text] [Related]
38. Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes.
Nishino K; Nakagawa K; Yase E; Terashima M; Murata T
Diabetol Int; 2023 Apr; 14(2):206-210. PubMed ID: 36575722
[TBL] [Abstract][Full Text] [Related]
39. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report.
Nguyen AD; Luong CQ; Chu HC; Nguyen VKD; Nguyen CV; Nguyen TA; Nguyen QH; Mai TD; Nguyen DV; Nguyen BQ; Tran TH; Dao PV; Nguyen DT; Nguyen NN; Do SN
BMC Endocr Disord; 2019 Nov; 19(1):121. PubMed ID: 31711488
[TBL] [Abstract][Full Text] [Related]
40. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
Hanna KS
Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
